Literature DB >> 7744662

Detection of platelet-bound and serum platelet-bindable antibodies for diagnosis of idiopathic thrombocytopenic purpura in dogs.

D C Lewis1, K M Meyers, M B Callan, J Bücheler, U Giger.   

Abstract

The sensitivity and specificity of 2 antibody tests for diagnosis of idiopathic thrombocytopenic purpura (ITP) in dogs were investigated prospectively. An ELISA to detect antibodies bound to the surface of platelets from affected dogs (direct test) was performed in 34 dogs with a clinical diagnosis of ITP and in 21 dogs with thrombocytopenia attributable to other causes. An ELISA to detect platelet-bindable antibodies in serum from affected dogs (indirect test) was performed in 32 dogs with ITP and in 15 dogs with other causes of thrombocytopenia. The direct test was positive in 32 of 34 dogs with ITP (sensitivity, 94%) and negative in 13 of 21 dogs with other causes of thrombocytopenia (specificity, 62%). Positive direct test results were obtained in 2 dogs with systemic lupus erythematosus, and in 1 dog each with concurrent Ehrlichia canis and Babesia canis infections, dirofilariasis, myelodysplasia, disseminated intravascular coagulation (of unknown cause), and thrombocytopenia subsequent to administration of trimethoprim/sulfadiazine, as well as in 1 dog with thrombocytopenia 14 days after a whole blood transfusion. The indirect test had positive results in 11 of 32 dogs with ITP (sensitivity, 34%) and negative results in 12 of 15 dogs with other causes of thrombocytopenia (specificity, 80%). Positive indirect test results were obtained in 1 dog each with systemic lupus erythematosus, concurrent E canis and B canis infections, and thrombocytopenia subsequent to administration of trimethoprim/sulfadiazine. Detection of platelet-bound antibodies was more sensitive than detection of serum-platelet bindable antibodies in confirming a diagnosis of ITP in dogs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744662

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  9 in total

1.  Clinical pathology interpretation.

Authors:  S Burton
Journal:  Can Vet J       Date:  1996-09       Impact factor: 1.008

2.  Babesiosis-associated immune thrombocytopenia.

Authors:  Roshni Narurkar; Aleksandra Mamorska-Dyga; Anup Agarwal; John C Nelson; Delong Liu
Journal:  Stem Cell Investig       Date:  2017-01-17

3.  Immune-mediated thrombocytopenia associated with angiostrongylus vasorum infection in a Jack Russell terrier.

Authors:  Emma Jo'neill; Els Acke; Emma Tobin; Grainne McCarthy
Journal:  Ir Vet J       Date:  2010-07-01       Impact factor: 2.146

4.  Platelet-bound antibodies detected by a flow cytometric assay in cats with thrombocytopenia.

Authors:  Barbara Kohn; Tanja Linden; Wolfgang Leibold
Journal:  J Feline Med Surg       Date:  2006-04-17       Impact factor: 2.015

5.  Detection and dynamics of anti-platelet antibodies in thrombocytopenic dogs with and without idiopathic immune thrombocytopenia.

Authors:  Sarah Shropshire; Steven Dow; Michael Lappin
Journal:  J Vet Intern Med       Date:  2020-02-18       Impact factor: 3.333

Review 6.  Immunomodulatory and immunosuppressive drug protocols in the treatment of canine primary immune thrombocytopenia, a scoping review.

Authors:  Peter Spanner Kristiansen; Lise Nikolic Nielsen
Journal:  Acta Vet Scand       Date:  2021-12-27       Impact factor: 1.695

Review 7.  A scoping review of autoantibodies as biomarkers for canine autoimmune disease.

Authors:  Amy E Treeful; Emily L Coffey; Steven G Friedenberg
Journal:  J Vet Intern Med       Date:  2022-02-22       Impact factor: 3.333

8.  Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim.

Authors:  Barbara Kohn; Gürkan Bal; Aleksandra Chirek; Sina Rehbein; Abdulgabar Salama
Journal:  BMC Vet Res       Date:  2016-06-10       Impact factor: 2.741

Review 9.  The Impact of Tick-Borne Diseases on the Bone.

Authors:  Imran Farooq; Tara J Moriarty
Journal:  Microorganisms       Date:  2021-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.